• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Precision Medical Devices Market

    ID: MRFR/MED/42329-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    US Precision Medical Device Market Research Report By Ecosystem Players Outlook (Pharmaceuticals and Biotechnology Companies Diagnostic Companies Healthcare IT Specialists/Big Data Companies Clinical Laboratories) By Sub-Markets Outlook (Companion Diagnostics Biomarker-Based Test Targeted Therapeutics Pharmacogenomics (PGX) Molecular Diagnostics) and By Therapeutics Outlook (Cancer/Oncology Cardiovascular Disease (CVD) Central Nervous System Infectious Diseases) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Precision Medical Device Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    US Precision Medical Devices Market Summary

    The US Precision Medical Device Market is projected to grow significantly from 235.94 USD Billion in 2024 to 541.32 USD Billion by 2035.

    Key Market Trends & Highlights

    US Precision Medical Device Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 7.84 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 541.32 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 235.94 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced technologies due to increasing healthcare demands is a major market driver.

    Market Size & Forecast

    2024 Market Size 235.94 (USD Billion)
    2035 Market Size 541.32 (USD Billion)
    CAGR (2025 - 2035) 7.84%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Tesla Inc (US), Meta Platforms Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    US Precision Medical Devices Market Trends

    The US Precision Medical Device Market is experiencing significant transformation, driven by advancements in technology and increasing demand for personalized healthcare solutions. One key market driver is the rising prevalence of chronic diseases, which necessitates the development of precise and innovative medical devices tailored to individual patient needs. The focus on enhancing patient outcomes through precision medicine is influencing manufacturers to invest in research and development, leading to the introduction of cutting-edge devices that integrate advanced diagnostic and therapeutic capabilities.

    Opportunities to be explored include the growing emphasis on telehealth and remote patient monitoring.As healthcare providers shift towards the digital space, there exists a growing opportunity for the development of precision medical devices that aid in remote diagnostics and treatment. This phenomenon has also correlated with the US government's pledge to widen telehealth services, especially in the aftermath of the pandemic, which has transformed patient care. Moreover, the transition toward value-based care models creates opportunities for other businesses to address the effectiveness and efficiency of their precision medical devices.

    In recent times, there has been an increased emphasis on regulations surrounding the efficacy and safety of medical devices, primarily due to the efforts of the FDA to improve validation times without compromising on quality.

    In addition, the increasing use of artificial intelligence and machine learning for device features is becoming commonplace, significantly improving the capabilities of precision medical devices in imaging and analyses. Another trend is the increasing use of these technologies to engage patients so that they can participate in their own healthcare decisions, thus increasing treatment adherence and compliance. In one way or another, these factors are redefining a modern and fast-changing environment for the US Precision Medical Device Market.

    The U.S. precision medical device market is poised for transformative growth, driven by advancements in technology and an increasing demand for personalized healthcare solutions.

    U.S. Food and Drug Administration (FDA)

    US Precision Medical Devices Market Drivers

    Technological Advancements

    The Global US Precision Medical Device Market Industry is experiencing rapid growth driven by technological advancements. Innovations in imaging technologies, robotics, and artificial intelligence are enhancing the precision and effectiveness of medical devices. For instance, the integration of AI in diagnostic tools allows for more accurate patient assessments, potentially reducing misdiagnosis rates. As these technologies evolve, they are expected to contribute significantly to the market's expansion, with projections indicating a market value of 235.94 USD Billion in 2024. This growth trajectory suggests that the industry is poised for further evolution, particularly as new technologies emerge.

    Market Segment Insights

    Get more detailed insights about US Precision Medical Device Market Research Report - Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The US Precision Medical Device Market is characterized by intense competition among various companies that manufacture highly specialized devices aimed at improving patient care and outcomes. The landscape is continually evolving, driven by technological advancements, regulatory changes, and growing consumer demand for minimally invasive procedures. Companies engage in aggressive research and development initiatives to innovate and introduce new products that can cater to specific medical needs. The marketplace consists of both established players with a robust portfolio of precision-driven devices and newer entrants aiming to carve out their niche by offering unique solutions.

    Additionally, partnerships, mergers, and acquisitions are common strategies within this market, allowing companies to enhance their capabilities and expand their market share effectively. Competitive insights encompass areas such as product offerings, market penetration, pricing strategies, and customer satisfaction, all of which play a significant role in determining the market dynamics and competitive landscape.Focusing on Medtronic, this company holds a strong position within the US Precision Medical Device Market, benefiting from a diverse product portfolio that includes advanced surgical instruments, diagnostic devices, and implantable technologies. Medtronic has established itself as a leader through its emphasis on technological innovation and patient-centric solutions.

    The company possesses extensive experience and research capabilities, along with a robust distribution network that ensures its products reach healthcare providers effectively. Medtronic's commitment to continuous improvement in quality and reliability fosters customer loyalty and enhances its reputation within the precision medical device sector in the US. The company’s ability to rapidly adapt to changing market demands and maintain compliance with stringent regulatory standards contributes significantly to its competitive advantage and market presence.Edwards Lifesciences is another prominent player in the US Precision Medical Device Market, notably recognized for its innovations in heart valve therapies and hemodynamic monitoring systems.

    The company's key products include transcatheter aortic valve replacement (TAVR) devices and other advanced hemodynamic monitoring solutions that emphasize precision and safety. Edwards Lifesciences has cultivated a strong reputation for its technological contributions that enhance patient outcomes and minimize surgical risks. The company's robust presence in the US market is bolstered further by strategic mergers and acquisitions, which have facilitated the expansion of its product range and market reach. The focus on high-quality, innovative solutions has positioned Edwards Lifesciences as a trusted partner for healthcare providers.

    Its strengths lie in a deep understanding of clinical needs and outcomes, allowing it to develop advanced devices that align with the demands of modern healthcare while continuing to elevate standards in patient care.

    Key Companies in the US Precision Medical Devices Market market include

    Industry Developments

    The US Precision Medical Device Market has seen significant developments recently, with companies like Medtronic, Edwards Lifesciences, and Boston Scientific leading innovations that improve patient outcomes and minimize invasive procedures. In July 2023, Medtronic announced advancements in its diabetes management devices, enhancing the integration of technology for better real-time monitoring. Additionally, Edwards Lifesciences introduced its new transcatheter heart valve systems, which have gained attention for their precision and effectiveness in treating heart valve diseases. In terms of mergers and acquisitions, Becton Dickinson completed its acquisition of C.R.

    Bard in April 2023, further consolidating its position in the surgical and vascular access markets. There has been notable market growth, with estimates indicating that the industry will reach a valuation of approximately $500 billion by 2025, driven by innovations and increased healthcare spending in the US. Furthermore, an expansion in telehealth and remote monitoring technologies has reshaped market dynamics since 2020, encouraging companies like Dexcom and Hologic to invest in digital health solutions tailored to patient needs. Enhanced regulatory frameworks are also paving the way for quicker approvals of precision devices, thereby boosting market confidence and investments.

    Future Outlook

    US Precision Medical Devices Market Future Outlook

    The US Precision Medical Device Market is poised for growth at 7.84% CAGR from 2024 to 2035, driven by technological advancements, increasing healthcare demands, and regulatory support.

    New opportunities lie in:

    • Invest in AI-driven diagnostic tools to enhance precision and efficiency.
    • Develop wearable devices for real-time health monitoring and data analytics.
    • Expand telehealth solutions integrating precision devices for remote patient management.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements in precision technology and increased healthcare accessibility.

    Market Segmentation

    Precision Medical Device Market Sub-Markets Outlook

    • Cancer/Oncology

    Precision Medical Device Market Therapeutics Outlook

    • Cancer/Oncology
    • Cardiovascular Disease (CVD)
    • Central Nervous System
    • Infectious Diseases

    Precision Medical Device Market Ecosystem Players Outlook

    • Companion Diagnostics

    Precision Medical Device Market Sub-Markets Outlook Insights

    Precision Medical Device Market Therapeutics Outlook Insights

    • Pharmaceuticals and Biotechnology Companies

    Precision Medical Device Market Ecosystem Players Outlook Insights

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 6.28(USD Billion)
    MARKET SIZE 2024 6.89(USD Billion)
    MARKET SIZE 2035 17.29(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.6% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Medtronic, Edwards Lifesciences, Smith and Nephew, Boston Scientific, Johnson and Johnson, Hologic, Thermo Fisher Scientific, Dexcom, NuVasive, Medline Industries, ResMed, Becton Dickinson, Abbott Laboratories, Stryker, LivaNova
    SEGMENTS COVERED Ecosystem Players Outlook, Sub-Markets Outlook, Therapeutics Outlook
    KEY MARKET OPPORTUNITIES Advancements in telehealth technology, Increasing demand for wearables, Growth in personalized medicine, Expanding regulatory support, Rising prevalence of chronic diseases
    KEY MARKET DYNAMICS Technological advancements, Regulatory compliance requirements, Rising aging population, Increased chronic diseases prevalence, Growing demand for personalized medicine
    COUNTRIES COVERED US

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the US Precision Medical Device Market in 2024?

    The US Precision Medical Device Market is expected to be valued at 6.89 billion USD in 2024.

    What will the market size be in 2035?

    By 2035, the US Precision Medical Device Market is projected to reach 17.29 billion USD.

    What is the expected CAGR for the US Precision Medical Device Market from 2025 to 2035?

    The market is expected to grow at a CAGR of 8.6% from 2025 to 2035.

    Who are the key players in the US Precision Medical Device Market?

    Major players in the market include Medtronic, Edwards Lifesciences, Smith and Nephew, and Johnson and Johnson.

    What is the market size for Pharmaceuticals and Biotechnology Companies in 2024?

    The market for Pharmaceuticals and Biotechnology Companies is valued at 2.07 billion USD in 2024.

    What is the expected market value for Diagnostic Companies by 2035?

    The market for Diagnostic Companies is projected to reach 4.64 billion USD by 2035.

    How much is the market for Healthcare IT Specialists valued at in 2024?

    In 2024, the market for Healthcare IT Specialists is valued at 1.54 billion USD.

    What is the projected market value for Clinical Laboratories by 2035?

    The Clinical Laboratories market is expected to reach 3.51 billion USD by 2035.

    What growth opportunities exist in the US Precision Medical Device Market?

    The market presents opportunities driven by advancements in technology and increasing healthcare demands.

    What challenges might the US Precision Medical Device Market face in the coming years?

    Challenges include regulatory hurdles and competition from emerging market players.

    1. \nTable\nof Contents\n\n\n\n\n\n\n\n \n\n\n \n\n\n\t\n\n\tEXECUTIVE\n\tSUMMARY
    2. \ \n\t\n\t\n\t\t\n\n\t\tMarket Overview \n\t\t\n\t\t\n\n\n\t\tKey Findings \n\t\t\n\t\t\n\n\n\t\tMarket Segmentation \n\t\t\n\t\t\n\n\n\t\tCompetitive Landscape \n\t\t\n\t\t\n\n\n\t\tChallenges and Opportunities\n\t\t
    3. \ \n\t\t\n\t\t\n\n\n\t\tFuture Outlook \n\t\t\n\t\n\n\n\n\n\n
    4. \n\n\n \n\n\n\t\n\n\tMARKET\n\tINTRODUCTION \n\t\n\t\n\t\t\n\n\t\tDefinition
    5. \ \n\t\t\n\t\t\n\n\n\t\tScope of the study \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tResearch
    6. Objective \n\t\t\t\n\t\t\t\n\n\n\t\t\tAssumption \n\t\t\t\n\t\t\t\n\n\n\t\t\tLimitations
    7. \ \n\t\t\t\n\t\t\n\n\t\n\n\t\n\n\n\tRESEARCH\n\tMETHODOLOGY
    8. \ \n\t\n\t\n\t\t\n\n\t\tOverview \n\t\t\n\t\t\n\n\n\t\tData
    9. Mining \n\t\t\n\t\t\n\n\n\t\tSecondary Research \n\t\t\n\t\t\n\n\n\t\tPrimary
    10. Research \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tPrimary Interviews and\n\t\t\tInformation
    11. Gathering Process \n\t\t\t\n\t\t\t\n\n\n\t\t\tBreakdown
    12. of Primary\n\t\t\tRespondents \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tForecasting
    13. Model \n\t\t\n\t\t\n\n\n\t\tMarket Size Estimation \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tBottom-Up
    14. Approach \n\t\t\t\n\t\t\t\n\n\n\t\t\tTop-Down Approach \n\t\t\t\n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tData
    15. Triangulation \n\t\t\n\t\t\n\n\n\t\tValidation \n\t\t\n\t\n\n\n\n\n\n
    16. \n\n\n \n\n\n\t\n\n\tMARKET\n\tDYNAMICS \n\t\n\t\n\t\t\n\n\t\tOverview
    17. \ \n\t\t\n\t\t\n\n\n\t\tDrivers \n\t\t\n\t\t\n\n\n\t\tRestraints
    18. \ \n\t\t\n\t\t\n\n\n\t\tOpportunities \n\t\t\n\t\n\n\t\n\n\n\tMARKET\n\tFACTOR
    19. ANALYSIS \n\t\n\t\n\t\t\n\n\t\tValue chain Analysis \n\t\t\n\t\t\n\n\n\t\tPorter's
    20. Five Forces\n\t\tAnalysis \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tBargaining
    21. Power of\n\t\t\tSuppliers \n\t\t\t\n\t\t\t\n\n\n\t\t\tBargaining
    22. Power of Buyers \n\t\t\t \n\t\t\t\n\t\t\t\n\n\n\t\t\tThreat
    23. of New Entrants \n\t\t\t \n\t\t\t\n\t\t\t\n\n\n\t\t\tThreat
    24. of Substitutes \n\t\t\t \n\t\t\t\n\t\t\t\n\n\n\t\t\tIntensity
    25. of Rivalry \n\t\t\t \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tCOVID-19
    26. Impact Analysis \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tMarket Impact Analysis
    27. \ \n\t\t\t \n\t\t\t\n\t\t\t\n\n\n\t\t\tRegional Impact \n\t\t\t\n\t\t\t\n\n\n\t\t\tOpportunity
    28. and Threat\n\t\t\tAnalysis \n\t\t\t\n\t\t\n\n\t\n\n\n\n\n\n
    29. \n\n\n \n\n\n\t\n\n\tU.S.\n\tPrecision Medical Device
    30. Market, BY Ecosystem Players Outlook (USD\n\tBillion) \n\t\n\t\n\t\t\n\n\t\tPharmaceuticals
    31. and\n\t\tBiotechnology Companies \n\t\t\n\t\t\n\n\n\t\tDiagnostic
    32. Companies \n\t\t\n\t\t\n\n\n\t\tHealthcare IT\n\t\tSpecialists/Big
    33. Data Companies \n\t\t\n\t\t\n\n\n\t\tClinical Laboratories \n\t\t\n\t\t\n\t\n\n\t\n\n\n\tU.S.\n\tPrecision
    34. Medical Device Market, BY Sub-Markets Outlook (USD\n\tBillion) \n\t\n\t\n\t\t\n\n\t\tCompanion
    35. Diagnostics \n\t\t\n\t\t\n\n\n\t\tBiomarker-Based Test \n\t\t\n\t\t\n\n\n\t\tTargeted
    36. Therapeutics \n\t\t\n\t\t\n\n\n\t\tPharmacogenomics (PGX) \n\t\t\n\t\t\n\n\n\t\tMolecular
    37. Diagnostics \n\t\t\n\t\t\n\t\n\n\t\n\n\n\tU.S.\n\tPrecision
    38. Medical Device Market, BY Therapeutics Outlook (USD\n\tBillion) \n\t\n\t\n\t\t\n\n\t\tCancer/Oncology
    39. \ \n\t\t\n\t\t\n\n\n\t\tCardiovascular Disease (CVD)\n\t\t \n\t\t\n\t\t\n\n\n\t\tCentral
    40. Nervous System \n\t\t\n\t\t\n\n\n\t\tInfectious Diseases \n\t\t\n\t\n\n\n\n\n\n
    41. \n\n\n \n\n\n\t\n\n\tCompetitive\n\tLandscape \n\t\n\t\n\t\t\n\n\t\tOverview
    42. \ \n\t\t\n\t\t\n\n\n\t\tCompetitive Analysis \n\t\t\n\t\t\n\n\n\t\tMarket
    43. share Analysis \n\t\t\n\t\t\n\n\n\t\tMajor Growth Strategy in
    44. the\n\t\tPrecision Medical Device Market \n\t\t\n\t\t\n\n\n\t\tCompetitive
    45. Benchmarking \n\t\t\n\t\t\n\t\t\n\n\n\t\tLeading Players in Terms
    46. of\n\t\tNumber of Developments in the Precision Medical Device Market \n\t\t\n\t\t\n\n\n\t\tKey
    47. developments and growth\n\t\tstrategies \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tNew
    48. Product Launch/Service\n\t\t\tDeployment \n\t\t\t\n\t\t\t\n\n\n\t\t\tMerger
    49. & Acquisitions \n\t\t\t \n\t\t\t\n\t\t\t\n\n\n\t\t\tJoint
    50. Ventures \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tMajor
    51. Players Financial\n\t\tMatrix \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tSales
    52. and Operating Income \n\t\t\t \n\t\t\t\n\t\t\t\n\n\n\t\t\tMajor
    53. Players R&D\n\t\t\tExpenditure. 2023 \n\t\t\t\n\t\t\n\n\t\n\n\t\n\n\n\tCompany\n\tProfiles
    54. \ \n\t\n\t\n\t\t\n\n\t\tMedtronic \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial
    55. Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey
    56. Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey
    57. Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tEdwards
    58. Lifesciences \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    59. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    60. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tSmith
    61. \ and Nephew \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview
    62. \ \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey
    63. Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey
    64. Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tBoston
    65. Scientific \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    66. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    67. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tJohnson
    68. \ and Johnson \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview
    69. \ \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey
    70. Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey
    71. Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tHologic
    72. \ \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    73. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    74. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tThermo
    75. Fisher Scientific \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview
    76. \ \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey
    77. Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey
    78. Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tDexcom
    79. \ \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    80. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    81. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tNuVasive
    82. \ \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    83. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    84. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tMedline
    85. Industries \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    86. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    87. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tResMed
    88. \ \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    89. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    90. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tBecton
    91. Dickinson \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    92. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    93. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tAbbott
    94. Laboratories \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    95. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    96. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tStryker
    97. \ \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    98. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    99. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\n\n\t\t\n\n\n\t\tLivaNova
    100. \ \n\t\t\n\t\t\n\t\t\t\n\n\t\t\tFinancial Overview \n\t\t\t\n\t\t\t\n\n\n\t\t\tProducts
    101. Offered \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Developments \n\t\t\t\n\t\t\t\n\n\n\t\t\tSWOT
    102. Analysis \n\t\t\t\n\t\t\t\n\n\n\t\t\tKey Strategies \n\t\t\t\n\t\t\t\n\t\t\n\n\t\n\n\t\n\n\n\tAppendix\n\t
    103. \ \n\t\n\t\n\t\t\n\n\t\tReferences \n\t\t\n\t\t\n\n\n\t\tRelated
    104. Reports \n\t\t\n\t\n\n\n\n\nLIST\nOf tables\n\n\n\n\n\n\t\n\n\tLIST\n\tOF
    105. ASSUMPTIONS\n\t \n\t\n\t\n\n\n\tU.S.\n\tPrecision Medical Device
    106. Market SIZE ESTIMATES & FORECAST, BY\n\tECOSYSTEM PLAYERS OUTLOOK, 2019-2035
    107. (USD Billions)\n\t \n\t\n\t\n\n\n\tU.S.\n\tPrecision Medical Device
    108. Market SIZE ESTIMATES & FORECAST, BY\n\tSUB-MARKETS OUTLOOK, 2019-2035 (USD
    109. Billions)\n\t \n\t\n\t\n\n\n\tU.S.\n\tPrecision Medical Device
    110. Market SIZE ESTIMATES & FORECAST, BY\n\tTHERAPEUTICS OUTLOOK, 2019-2035 (USD
    111. Billions)\n\t \n\t\n\t\n\n\n\tPRODUCT\n\tLAUNCH/PRODUCT DEVELOPMENT/APPROVAL\n\t
    112. \ \n\t\n\t\n\n\n\tACQUISITION/PARTNERSHIP\n\t \n\t\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nLIST\nOf
    113. MEDICAL DEVICE MARKET ANALYSIS BY ECOSYSTEM PLAYERS\n\tOUTLOOK \n\t\n\t\n\n\n\tU.S.\n\tPRECISION
    114. MEDICAL DEVICE MARKET ANALYSIS BY SUB-MARKETS OUTLOOK \n\t\n\t\n\n\n\tU.S.\n\tPRECISION
    115. MEDICAL DEVICE MARKET ANALYSIS BY THERAPEUTICS OUTLOOK \n\t\n\t\n\n\n\tKEY\n\tBUYING
    116. CRITERIA OF PRECISION MEDICAL DEVICE MARKET \n\t\n\t\n\n\n\tRESEARCH\n\tPROCESS
    117. OF MRFR \n\t\n\t\n\n\n\tDRO\n\tANALYSIS OF PRECISION MEDICAL DEVICE
    118. MARKET \n\t\n\t\n\n\n\tDRIVERS\n\tIMPACT ANALYSIS: PRECISION MEDICAL
    119. DEVICE MARKET \n\t\n\t\n\n\n\tRESTRAINTS\n\tIMPACT ANALYSIS: PRECISION
    120. MEDICAL DEVICE MARKET \n\t\n\t\n\n\n\tSUPPLY\n\t/ VALUE CHAIN: PRECISION
    121. MEDICAL DEVICE MARKET \n\t\n\t\n\n\n\tPRECISION\n\tMEDICAL DEVICE
    122. MARKET, BY ECOSYSTEM PLAYERS OUTLOOK, 2024 (% SHARE) \n\t\n\t\n\n\n\tPRECISION\n\tMEDICAL
    123. DEVICE MARKET, BY ECOSYSTEM PLAYERS OUTLOOK, 2019 TO 2035\n\t(USD Billions) \n\t\n\t\n\n\n\tPRECISION\n\tMEDICAL
    124. DEVICE MARKET, BY SUB-MARKETS OUTLOOK, 2024 (% SHARE) \n\t\n\t\n\n\n\tPRECISION\n\tMEDICAL
    125. DEVICE MARKET, BY SUB-MARKETS OUTLOOK, 2019 TO 2035 (USD\n\tBillions) \n\t\n\t\n\n\n\tPRECISION\n\tMEDICAL
    126. DEVICE MARKET, BY THERAPEUTICS OUTLOOK, 2024 (% SHARE) \n\t\n\t\n\n\n\tPRECISION\n\tMEDICAL
    127. DEVICE MARKET, BY THERAPEUTICS OUTLOOK, 2019 TO 2035 (USD\n\tBillions) \n\t\n\t\n\n\n\tBENCHMARKING\n\tOF
    128. MAJOR COMPETITORS \n\t\n\n\n\n\n\n\n\n

    U.S. Precision Medical Device Market Segmentation

    • Precision Medical Device Market By Ecosystem Players Outlook (USD Billion, 2019-2035)

      • Pharmaceuticals and Biotechnology Companies
      • Diagnostic Companies
      • Healthcare IT Specialists/Big Data Companies
      • Clinical Laboratories
    • Precision Medical Device Market By Sub-Markets Outlook (USD Billion, 2019-2035)

      • Companion Diagnostics
      • Biomarker-Based Test
      • Targeted Therapeutics
      • Pharmacogenomics (PGX)
      • Molecular Diagnostic
    • Precision Medical Device Market By Therapeutics Outlook (USD Billion, 2019-2035)

      • Cancer/Oncology
      • Cardiovascular Disease (CVD)
      • Central Nervous System
      • Infectious Diseases
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials